All Things Urticaria – Learning about urticaria with Prof. Dr. Torsten Zuberbier

Professor Marcus Maurer is joined by the president of Global Allergy & Airways Patient Platform (GAAPP), Tonya Winders, for a special Urticaria Day (UDAY) episode to discuss the role patient advocacy groups play in supporting individuals with chronic spontaneous urticaria. Both experts explore patient unmet needs and highlight methods clinicians can use to help overcome these barriers. Do you...

Dr Désirée Larenas-Linnemann and Professor Marcus Maurer delve into best practices for urticaria management in resource-poor settings, underlining the crucial role of accurate diagnosis and adherence to established guidelines. They also address trending topics in angioedema and urticaria treatment, such as antihistamine up-dosing and the complexities surrounding triple-combination therapies and th...

Professor Marcus Maurer is joined by Professor Paula Busse to explore the multifaceted burdens of angioedema for patients and physicians. They discuss issues surrounding timely diagnosis, interpreting ambiguous symptoms, patient concerns about medications, and enhancing quality of life monitoring. Utilise the following external links to access additional resources relating to the topics discussed...

Dr Régis de Albuquerque Campos joins Professor Marcus Maurer to discuss the implications of angioedema and its impact on people living with chronic spontaneous urticaria (CSU). Dr Campos highlights diverse aspects of the burden of CSU and the impact misdiagnosis has on quality of life. Professor Maurer provides an overview of the current treatment landscape, differential diagnosis, unmet needs in...

Professor Markus Magerl joins Professor Marcus Maurer in this episode to explore the significance of differential diagnosis in the identification of angioedema in chronic spontaneous urticaria (CSU). Professor Magerl takes a deep dive into the prospective use of artificial intelligence (AI) in the analysis of data derived from a questionnaire utilising algorithmic models. Both professors, Maurer a...

Professor Marcus Maurer is joined by Dr Aistė Ramanauskaitė to explore the CRUSE app's potential advantages for individuals suffering from chronic spontaneous urticaria. Professor Maurer emphasises the importance and utilisation of the CRUSE app, while Dr. Ramanauskaitė delves into the various benefits and practical applications offered by the app. Do you have suggestions for future episodes? Plea...

Professor Martin Metz joins Professor Marcus Maurer to answer an audience proposed question focusing on what will guide physicians in the recommendations for individual patients to identify the most beneficial treatment option to treat chronic spontaneous and inducible urticaria. Both experts delve into the current treatment options available, and exciting treatments that are currently in clinical...

Professor Marcus Maurer is joined by GP Dr Dermot Ryan to discuss the role of GPs in the diagnosis and management of chronic urticaria. Professor Maurer and Dr Ryan highlight the positive impact that physicians have in limiting patient distress while increasing patient confidence, despite the time-limited interactions. They also explore the impact of mistreatment on a patient’s life. Do you have s...

Professor Marcus Maurer asks Dr Sherezade Moñino-Romero about her research into soluble IgE receptor and its potential as a marker of treatment response in chronic urticaria. They also discuss the art of communicating science to the public and why it is so vital to do it effectively. Do you have suggestions for future episodes? Please provide feedback and offer your suggestions for future topics a...

Professor Marcus Maurer is accompanied by Professor Marc Riedl to delve into the symptomatology and pathophysiology of angioedema in chronic spontaneous urticaria (CSU). The mechanistic aetiology of angioedema within the context of CSU pathology is also explored. Professor Marc Riedl examines therapeutic treatments for patients concurrently experiencing angioedema in CSU while exploring how the ch...

Professor Karla Arruda and Professor Marcus Maurer discuss the development and implementation of UCARE in Brazil, and its potential benefits for individuals suffering from chronic spontaneous urticaria (CSU). The conversation extends towards exploring the framework of the Brazilian UCARE centres and projects, and how it can be implemented in other countries. Professor Maurer delves into the clinic...

Professors Marcus Maurer and Luis Felipe Ensina deliberate on the most recent findings that emerged at The American Academy of Allergy, Asthma & Immunology (AAAAI) conference held in San Antonio, Texas. In particular, Professor Maurer discusses poster presentations concerning the efficacious use of omalizumab and dupilumab for the management of urticaria. Professor Ensina expands the discussio...

Dr. Murat Türk has joined Professor Marcus Maurer to discuss biomarkers in chronic spontaneous urticaria (CSU), focusing on immunoglobulin E (IgE) in particular. They emphasise the importance of using IgE testing appropriately in the treatment of CSU; as a prognostic parameter rather than a diagnostic technique. The discussion expands into a comparison between basophil testing and IgE testing and...

Professor Marcus Maurer is joined by Dr Melba Munoz to take a deep dive into symptomatic dermographism. The discussion aims to explain the involvement of mast cells in CSU patients and attempts to answer some ongoing questions to help unravel the pathogenesis of dermographism in chronic urticaria.

Dr Pavel Kolkhir joins Professor Marcus Maurer to discuss the Chronic Urticaria Registry (CURE). The discussion includes explanations of the aims of CURE in collecting quality, real-life data on chronic urticaria patient characteristics, the course of disease, underlying causes, comorbidities, treatment responses, quality of life impairment and health care costs.

Professor Marcus Maurer is joined by Dr Jie Li to discuss the role  the gut microbiome plays in the disease progression of CSU. A particular focus is given to metabolism and homeostasis in patients with CSU, how the gut microbiome can impact CSU presentation, and the impact it can have on the efficacy of treatments such as antihistamines.

Professor Alicja Kasperska-Zajac joins Professor Marcus Maurer to discuss a rare form of chronic inducible urticaria – delayed pressure urticaria. The discussion highlights the difficulties in undertaking differential diagnosis and the main differences when compared to chronic spontaneous urticaria, namely the absence of oedema and wheals.

Professor Yoshimichi Okayama joins Professor Marcus Maurer to discuss the role which mast cells play in the disease aetiology of chronic spontaneous urticaria. In particular, the discussion focuses on mast cell receptors and how they can be utilised in the diagnosis of CSU.

Professor Marcus Maurer is joined by Professor Asli Gelincik as they discuss recurrent angioedema in chronic spontaneous urticaria, and treatment options which are currently available to alleviate this pathology. The mechanistic actions of mast cell-mediated angioedema and bradykinin-mediated angioedema are discussed and their implications are analysed.

Dr Heike Röckmann, head of the drug survivability of omalizumab in chronic urticaria (DruSO-CU) project joins Professor Marcus Maurer to discuss the global project, the difficulties which were encountered, and how the UCARE network helped overcome these challenges. The focus of this podcast is on the importance of identifying the data in this important project.

In this episode, Professor Silvia Ferrucci joins Professor Marcus Maurer in discussing what the phrase ‘Never Give Up’ means to physicians treating urticaria, and for patients embarking on their treatment journey. Areas of special focus are given to guideline treatment algorithms and the implementation of the CRUSE app and Chronic Urticaria Registry (CURE) as tools to shift the balance of treating...

Professor Marcus Maurer is joined by Professor Luis Felipe Ensina where they discuss the founding days of urticaria treatment, and how urticaria clinics became available. Professor Maurer and Professor Ensina discussed how the treatment landscape, diagnostic techniques and further developments in the advancement of how clinicians treat patients with urticaria have evolved over the last two decades...

Professor Anna Zalewska-Janowska joins Professor Maurer to delve into fascinating area of psycho-neurodermatology and how this can impact the lives of individuals with urticaria. Prof. Zalewska-Janowska highlights the importance of how urticaria is linked to neurogenic inflammation in chronic urticaria.

In this episode Professor Marcus Maurer is joined by patient and patient advocate Elaine, who experiences chronic urticaria. She highlights the importance of connecting patients with each other, and discusses the opportunities that arise when patients work together with healthcare professionals.

Dr Sinisa Savic joins Professor Dr Marcus Maurer in this podcast to discuss chronic urticarias and systemic auto-inflammatory syndromes, delving into differential diagnostic techniques and utilisation of genetics to determine causation of clinical presentations.